Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study

Frontiers in Genetics

Volumn 6, Issue SEP, 2015, Pages

  Das, Mithun ^a   Irvin, M Ryan ^a   Sha, Jin ^a   Aslibekyan, Stella ^a   Hidalgo, Bertha ^a   Perry, Rodney T ^a   Zhi, Degui ^a   Tiwari, Hemant K ^a   Absher, Devin ^b   Ordovas, Jose M ^c   Arnett, Donna K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; DNA methylation; Dyslipidemia; Epigenetic changes; Fenofibrate; Lipid lowering drug

Indexed keywords

ABC TRANSPORTER A1; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; DNA METHYLATION; FAT INTAKE; FEMALE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; TREATMENT RESPONSE;

EID: 84944721667     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2015.00304     Document Type: Article

References (34)

1. Absher, D. M., Li, X., Waite, L. L., Gibson, A., Roberts, K., Edberg, J., et al. (2013). Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 9:e1003678. doi: 10.1371/journal.pgen.1003678
2. Aslibekyan, S., Demerath, E. W., Mendelson, M., Zhi, D., Guan, W., Liang, L., et al. (2015). Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference. Obesity (Silver Spring) 23, 1493-1501. doi: 10.1002/oby.21111
3. Aslibekyan, S., Kabagambe, E. K., Irvin, M. R., Straka, R. J., Borecki, I. B., Tiwari, H. K., et al. (2012). A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network. Pharmacogenet. Genomics 22, 191-197. doi: 10.1097/FPC.0b013e32834fdd41
4. Atkinson, B., and Therneau, T. (2003). The kinship package (for R). Software copyright Mayo Foundation for Medical Education and Research. Available online at: http://ftp.uni-bayreuth.de/math/statlib/R/CRAN/doc/packages/kinship.pdf
5. Auwerx, J., Schoonjans, K., Fruchart, J. C., and Staels, B. (1996). Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis 124(Suppl.), S29-S37. doi: 10.1016/0021-9150(96)05854-6
6. Benton, M. C., Johnstone, A., Eccles, D., Harmon, B., Hayes, M. T., Lea, R. A., et al. (2015). An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss. Genome Biol. 16:8. doi: 10.1186/s13059-014-0569-x
7. Chen, C., Grennan, K., Badner, J., Zhang, D., Gershon, E., Jin, L., et al. (2011). Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods. PLoS ONE 6:e17238. doi: 10.1371/journal.pone.0017238
8. Crujeiras, A. B., Campion, J., D�az-Lagares, A., Milagro, F. I., Goyenechea, E., Abete, I., et al. (2013). Association of weight regain with specific methylation levels in the NPY and POMC promoters in leukocytes of obese men: a translational study. Regul. Pept. 186, 1-6. doi: 10.1016/j.regpep.2013.06.012
9. Deiuliis, J., Mihai, G., Zhang, J., Taslim, C., Varghese, J. J., Maiseyeu, A., et al. (2014). Renin-sensitive microRNAs correlate with atherosclerosis plaque progression. J. Hum. Hypertens. 28, 251-258. doi: 10.1038/jhh.2013.97
10. Feitosa, M. F., An, P., Ordovas, J. M., Ketkar, S., Hopkins, P. N., Straka, R. J., et al. (2011). Association of gene variants with lipid levels in response to fenofibrate is influenced by metabolic syndrome status. Atherosclerosis 215, 435-439. doi: 10.1016/j.atherosclerosis.2011.01.011
11. Foucher, C., Brug�re, L., and Ansquer, J. C. (2010). Fenofibrate, homocysteine and renal function. Curr. Vasc. Pharmacol. 8, 589-603. doi: 10.2174/157016110792006987
12. Frazier-Wood, A. C., Aslibekyan, S., Absher, D. M., Hopkins, P. N., Sha, J., Tsai, M. Y., et al. (2014). Methylation at CPT1A locus is associated with lipoprotein subfraction profiles. J. Lipid Res. 55, 1324-1330. doi: 10.1194/jlr.M048504
13. Frazier-Wood, A. C., Ordovas, J. M., Straka, R. J., Hixson, J. E., Borecki, I. B., Tiwari, H. K., et al. (2013). The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study. Pharmacogenomics J. 13, 312-317. doi: 10.1038/tpj.2012.9
14. Fruchart, J. C., and Duriez, P. (2006). Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. Drugs Today (Barc). 42, 39-64. doi: 10.1358/dot.2006.42.1.963528
15. Hidalgo, B., Irvin, M. R., Sha, J., Zhi, D., Aslibekyan, S., Absher, D., et al. (2014). Epigenome-wide association study of fasting measures of glucose, insulin, and HOMA-IR in the genetics of lipid lowering drugs and diet network study. Diabetes 63, 801-807. doi: 10.2337/db13-1100
16. Hutvagner, G., and Simard, M. J. (2008). Argonaute proteins: key players in RNA silencing. Nat. Rev. Mol. Cell Biol. 9, 22-32. doi: 10.1038/nrm2321
17. Irvin, M. R., Zhi, D., Joehanes, R., Mendelson, M., Aslibekyan, S., Claas, S. A., et al. (2014). Epigenome-wide association study of fasting blood lipids in the Genetics of Lipid-lowering Drugs and Diet Network study. Circulation 130, 565-572. doi: 10.1161/CIRCULATIONAHA.114.009158
18. Jacobsen, S. C., Gillberg, L., Bork-Jensen, J., Ribel-Madsen, R., Lara, E., Calvanese, V., et al. (2014). Young men with low birthweight exhibit decreased plasticity of genome-wide muscle DNA methylation by high-fat overfeeding. Diabetologia 57, 1154-1158. doi: 10.1007/s00125-014-3198-8
19. Lai, C. Q., Arnett, D. K., Corella, D., Straka, R. J., Tsai, M. Y., Peacock, J. M., et al. (2007). Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study. Arterioscler. Thromb. Vasc. Biol. 27, 1417-1425. doi: 10.1161/ATVBAHA.107.140103
20. Li, L., Chen, Y., Doan, J., Murray, J., Molkentin, J. D., and Liu, Q. (2014). Transforming growth factor beta-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling. Circulation 130, 2162-2172. doi: 10.1161/CIRCULATIONAHA.114.011195
21. Liu, S., Nheu, T., Luwor, R., Nicholson, S. E., and Zhu, H. J. (2015). SPSB1, a novel negative regulator of the transforming growth factor-beta signaling pathway targeting the type II receptor. J. Biol. Chem. 290, 17894-17908. doi: 10.1074/jbc.M114.607184
22. Liu, Y., Ordovas, J. M., Gao, G., Province, M., Straka, R. J., Tsai, M. Y., et al. (2008). The SCARB1 gene is associated with lipid response to dietary and pharmacological interventions. J. Hum. Genet. 53, 709-717. doi: 10.1007/s10038-008-0302-2
23. Mart�n-N��ez, G. M., Cabrera-Mulero, R., Rubio-Mart�n, E., Rojo-Mart�nez, G., Olveira, G., Vald�s, S., et al. (2014). Methylation levels of the SCD1 gene promoter and LINE-1 repeat region are associated with weight change: an intervention study. Mol. Nutr. Food Res. 58, 1528-1536. doi: 10.1002/mnfr.201400079
24. Milenkovic, D., Vanden Berghe, W., Boby, C., Leroux, C., Declerck, K., Szarc Vel Szic, K., et al. (2014). Dietary flavanols modulate the transcription of genes associated with cardiovascular pathology without changes in their DNA methylation state. PLoS ONE 9:e95527. doi: 10.1371/journal.pone.0095527
25. R�nn, T., Volkov, P., Daveg�rdh, C., Dayeh, T., Hall, E., Olsson, A. H., et al. (2013). A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet. 9:e1003572. doi: 10.1371/journal.pgen.1003572
26. Schoonjans, K., Staels, B., and Auwerx, J. (1996). The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302, 93-109. doi: 10.1016/0005-2760(96)00066-5
27. Smith, C. E., Arnett, D. K., Tsai, M. Y., Lai, C. Q., Parnell, L. D., Shen, J., et al. (2009). Physical inactivity interacts with an endothelial lipase polymorphism to modulate high density lipoprotein cholesterol in the GOLDN study. Atherosclerosis 206, 500-504. doi: 10.1016/j.atherosclerosis.2009.03.012
28. Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., and Fruchart, J. C. (1998). Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088-2093. doi: 10.1161/01.CIR.98.19.2088
29. Staels, B., Schoonjans, K., Fruchart, J. C., and Auwerx, J. (1997). The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs). Biochimie 79, 95-99. doi: 10.1016/S0300-9084(97)81497-6
30. Su, J., Li, X., Yu, Q., Liu, Y., Wang, Y., Song, H., et al. (2014). Association of P2Y12 gene promoter DNA methylation with the risk of clopidogrel resistance in coronary artery disease patients. Biomed Res. Int. 2014:450814. doi: 10.1155/2014/450814
31. Tsai, M. Y., Ordovas, J. M., Li, N., Straka, R. J., Hanson, N. Q., Arends, V. L., et al. (2010). Effect of fenofibrate therapy and ABCA1 polymorphisms on high-density lipoprotein subclasses in the Genetics of Lipid Lowering Drugs and Diet Network. Mol. Genet. Metab. 100, 118-122. doi: 10.1016/j.ymgme.2010.03.001
32. van der Hoogt, C. C., de Haan, W., Westerterp, M., Hoekstra, M., Dallinga-Thie, G. M., Romijn, J. A., et al. (2007). Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression. J. Lipid Res. 48, 1763-1771. doi: 10.1194/jlr.M700108-JLR200
33. Wojczynski, M. K., Gao, G., Borecki, I., Hopkins, P. N., Parnell, L., Lai, C. Q., et al. (2010). Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study. J. Lipid Res. 51, 3316-3323. doi: 10.1194/jlr.P001834
34. Wood, A. C., Kabagambe, E. K., Borecki, I. B., Tiwari, H. K., Ordovas, J. M., and Arnett, D. K. (2011). Dietary carbohydrate modifies the inverse association between saturated fat intake and cholesterol on very low-density lipoproteins. Lipid Insights 2011, 7-15. doi: 10.4137/LPI.S7659